| 2026-09-14 | United States | Settlement | Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula U.S. Department of Justice + 1 more reports | $384M / $384,999,040 |
| 2024 | United States | Judgment against company | On July 26, 2024, a jury ordered Abbott Laboratories to pay $495 million in the case of Margo Gill vs. Abbott Laboratories, comprising $95 million in compensatory damages and $400 million in punitive Wikipedia: Abbott Laboratories（Litigation and controversies） + 1 more reports | $495 million / $95 million / $400 million |
| 2022-05-16 | United States | Filed / under investigation | Justice Department Files Complaint and Proposed Consent Decree to Ensure Safety of Abbott Laboratories’ Infant Formula U.S. Department of Justice + 1 more reports | — |
| 2022 | United States | Other | In February 2022, Abbott recalled baby formulas from the market and shut down its Michigan plant after complaints of illness and death in infants caused by serious bacterial infections. Following Abbo Wikipedia: Abbott Laboratories（Litigation and controversies） | — |
| 2021 | United States | Settlement | In 2021, two of Abbott Laboratories' subsidiaries, Arriva Medical LLC and Alere Inc, had to pay $160m to resolve claims that it had fraudulently billed Medicare for glucose monitors. The US Department Wikipedia: Abbott Laboratories（Litigation and controversies） | $160m |
| 2018-10-26 | United States | Settlement | Abbott Laboratories and AbbVie Inc. to Pay $25 Million to Resolve False Claims Act Allegations of Kickbacks and Off-Label Marketing of the Drug TriCor® U.S. Department of Justice + 1 more reports | $25 Million |
| 2017-10-12 | United States | Other | Sidney Hillman Health Center o v. Abbott Laboratories, Incorpora Court of Appeals for the Seventh Circuit | — |
| 2015-04-13 | United States | Filed / under investigation | Sidney Hillman Health Center o v. Abbott Laboratories, Incorpora Court of Appeals for the Seventh Circuit | — |
| 2013-12-27 | United States | Settlement | Abbott Laboratories Pays U.S. $5.475 Million to Settle Claims That Company Paid Kickbacks to Physicians U.S. Department of Justice + 1 more reports | $5.475 Million |
| 2013-11-14 | United States | Other | U.S. Attorney Heaphy Presents Members Of Abbott Prosecution Team With Department Of Justice Achievement Award U.S. Department of Justice | — |
| 2012-10-02 | United States | Fine / administrative sanction | Abbott Laboratories Sentenced for Misbranding Drug U.S. Department of Justice | $500 million / $198.5 million / $1.5 million |
| 2012 | United States | Settlement | 2012 | Abbott Laboratories | $1.5 billion | Off-label promotion | Depakote | False Claims Act, FDCA Wikipedia: List of largest pharmaceutical settlements + 2 more reports | $1.5 billion / $700 million / $800 million |
| 2012 | United States | Fine / administrative sanction | On 2 October 2012, the company was charged with a $500 million fine and $198.5 million forfeiture for illegal marketing of Depakote for uses not approved by the FDA. The court also sentenced Abbott to Wikipedia: Abbott Laboratories（Litigation and controversies） | $500 million / $198.5 million |
| 2011-10-12 | United States | Filed / under investigation | United States ex rel. King v. Solvay S.A. District Court, S.D. Texas | — |
| 2010-12-07 | United States | Settlement | Kos Pharmaceuticals to Pay More Than $41 Million to Resolve Kickback and Off-Label Promotion Allegations U.S. Department of Justice + 1 more reports | $41 Million |
| 2004 | United Kingdom | Judgment against company | Abbott was required to pay CAT US$255 million in lieu of royalties the MRC, the Scripps Research Institute and Stratagene would have received on sales of Humira after December 2004. Some of this sum w Wikipedia: Abbott Laboratories（Litigation and controversies） | US$255 million |
| 2003 | United Kingdom | Judgment against company | In March 2003, British company Cambridge Antibody Technology (CAT) stated its wish to "initiate discussions regarding the applicability of the royalty offset provisions for Humira" ( Adalimumab ) with Wikipedia: Abbott Laboratories（Litigation and controversies） | — |
| 2003 | United States | Settlement | In October 2003, Abbott Laboratories and two of its units agreed to pay a total of $600 million in the first combined civil settlement and criminal conviction for offering kickbacks to agents of "Oper Wikipedia: Abbott Laboratories（Litigation and controversies） | $600 million |
| 2001 | United States | Settlement | In October 2001, the US Department of Justice, states attorneys general, and TAP Pharmaceutical Products, a subsidiary of Abbott Laboratories, settled criminal and civil charges against TAP related to Wikipedia: Abbott Laboratories（Litigation and controversies） | $875 million / $290 million / $559.5 million |